Evidence map›Paper›PMID 34631601›Full record

Trial reportFrontiers in cellular and infection microbiology2021

The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment.

Veda D Khadka, Felix M Key, Carolina Romo-González, Adrián Martínez-Gayosso, Blanca L Campos-Cabrera, Armando Gerónimo-Gallegos, Tucker C Lynn, Carola Durán-McKinster, Rafael Coria-Jiménez, Tami D Lieberman and 1 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2026
    Review
  5. Article
  6. Review
  7. Alterations of the skin microbiome in HIV infection with pruritus.Frontiers in cellular and infection microbiology · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Toward the Next Generation of In Silico Modeling of Dynamic Host-Microbiota Interactions in the Skin.JID innovations : skin science from molecules to population health · 2025
    Review
  15. Review
  16. Review
  17. Pathogens (Basel, Switzerland) · 2025
    Review
  18. Langerhans cells: Central players in the pathophysiology of atopic dermatitis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Veda D KhadkaInstitute for Medical Engineering and Sciences, Massachusetts Institute of Technology, Cambridge, MA, United States.
Felix M KeyInstitute for Medical Engineering and Sciences, Massachusetts Institute of Technology, Cambridge, MA, United States.
Carolina Romo-GonzálezExperimental Bacteriology Laboratory, National Institute of Pediatrics, Mexico City, Mexico.
Adrián Martínez-GayossoDepartment of Dermatology, National Institute of Pediatrics, Mexico City, Mexico.
Blanca L Campos-CabreraDepartment of Dermatology, National Institute of Pediatrics, Mexico City, Mexico.
Armando Gerónimo-GallegosExperimental Bacteriology Laboratory, National Institute of Pediatrics, Mexico City, Mexico.
Tucker C LynnInstitute for Medical Engineering and Sciences, Massachusetts Institute of Technology, Cambridge, MA, United States.
Carola Durán-McKinsterDepartment of Dermatology, National Institute of Pediatrics, Mexico City, Mexico.
Rafael Coria-JiménezExperimental Bacteriology Laboratory, National Institute of Pediatrics, Mexico City, Mexico.
Tami D LiebermanInstitute for Medical Engineering and Sciences, Massachusetts Institute of Technology, Cambridge, MA, United States.
Maria T García-RomeroDepartment of Dermatology, National Institute of Pediatrics, Mexico City, Mexico.
Massachusetts Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Atopic dermatitis (AD) is characterized by an altered skin microbiome dominantly colonized by Objectives: To characterize changes in the skin microbiome during treatment for AD. Methods: The skin microbiomes of children with moderate-to-severe AD and healthy children were investigated in a longitudinal prospective study. Patients with AD were randomized to receive either standard treatment with emollients and topical corticosteroids or standard treatment with the addition of dilute bleach baths (DBB) and sampled at four visits over a three-month period. At each visit, severity of AD was measured, swabs were taken from four body sites and the composition of the microbiome at those sites was assessed using 16S rRNA amplification. Results: We included 14 healthy controls and 28 patients. We found high relative abundances of Conclusions: There are clear differences in the skin microbiome of healthy controls and AD patients that diminish with treatment. After three months, the addition of DBB to standard treatment had significantly decreased the

Indexed as

Dermatitis, AtopicMicrobiotaChildHumansProspective StudiesRNA, Ribosomal, 16SSkinStaphylococcus aureusRNA, Ribosomal, 16Satopic dermatitis (AD)microbiome & dysbiosismicrobiota (16S)skintherapeutics

Identifiers

PMID34631601
PMCPMC8498027
OpenAlexW3203507177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.